Superworth

DocGo profit margin DCGO

Gross, operating and net profit as a share of revenue over the last twelve months, from 2021.

Net margin, 12 months
−65.3%
Operating margin, 12 months
−62.2%
Net margin on a year earlier
−61.1 pts
Peer median
6.8%

Over the twelve months to Jun 30, 2026, DocGo kept −65.3% of its revenue as net profit, with an operating margin of −62.2% and a gross margin of 30.1%.

The median for 10 healthcare stocks of a similar size is 6.8%.

Profit margin over time

GrossOperatingNet

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearNet marginOperating marginGross margin
FY2025−56.6%−55.3%30.7%
FY20243.2%4.7%34.6%
FY20231.1%2.4%31.3%
FY20227.9%5.0%35.1%
FY20217.4%4.8%34.6%

Quarter by quarter

QuarterEndedNet margin, 12 monthsChange on a yearOperating margin
Q2 FY26−65.3%−61.1 pts−62.2%
Q1 FY26−62.2%−62.1 pts−60.6%
Q4 FY25−56.6%−59.9 pts−55.3%
Q3 FY25−14.0%−18.5 pts−22.0%
Q2 FY25−4.2%−8.3 pts−6.6%
Q1 FY25−0.1%−3.2 pts−0.2%
Q4 FY243.2%+2.1 pts4.7%
Q3 FY244.4%+3.1 pts6.9%
Q2 FY244.1%+2.8 pts6.2%
Q1 FY243.1%−1.6 pts5.4%
Q4 FY231.1%−6.8 pts2.4%
Q3 FY231.4%−10.0 pts0.6%

Against its peers

Companies in Healthcare nearest DocGo's size, closest first, today.

CompanyProfit margin
DCGODocGo−65.3%
NEPHNephros8.4%
ATNMActinium Pharmaceuticalsn/m
APTAlpha Pro Tech6.8%
SPROSpero Therapeutics15.7%
LFVNLifevantage2.8%
ICCCImmucell2.6%
KEQUKewaunee Scientific3.0%
PDEXPro DEX17.6%
PLXProtalix BioTherapeutics23.5%
NATRNatures Sunshine Products3.7%
Peer median6.8%

Where DocGo ranks

What the profit margin tells you

Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).

Compare within an industry. 10% is superb for a retailer and poor for a software company.

More on DocGo

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.